Embla Medical hf
CSE:EMBLA
Balance Sheet
Balance Sheet Decomposition
Embla Medical hf
Embla Medical hf
Balance Sheet
Embla Medical hf
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
4
|
11
|
4
|
4
|
21
|
12
|
16
|
31
|
80
|
54
|
20
|
22
|
42
|
28
|
26
|
35
|
37
|
56
|
59
|
102
|
85
|
77
|
73
|
86
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
28
|
77
|
51
|
0
|
0
|
42
|
28
|
26
|
35
|
37
|
56
|
58
|
102
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
4
|
11
|
4
|
4
|
21
|
12
|
16
|
3
|
3
|
3
|
20
|
22
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
85
|
77
|
73
|
86
|
|
| Short-Term Investments |
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Receivables |
9
|
14
|
17
|
19
|
32
|
58
|
53
|
45
|
45
|
54
|
55
|
53
|
75
|
73
|
78
|
85
|
96
|
108
|
116
|
112
|
107
|
117
|
133
|
129
|
|
| Accounts Receivables |
8
|
12
|
15
|
16
|
28
|
49
|
47
|
44
|
44
|
52
|
53
|
53
|
71
|
69
|
73
|
82
|
93
|
104
|
107
|
98
|
103
|
112
|
128
|
122
|
|
| Other Receivables |
1
|
1
|
2
|
3
|
3
|
9
|
5
|
1
|
2
|
2
|
2
|
0
|
4
|
4
|
4
|
3
|
3
|
4
|
10
|
14
|
4
|
4
|
6
|
7
|
|
| Inventory |
8
|
12
|
12
|
15
|
26
|
47
|
54
|
56
|
44
|
46
|
52
|
57
|
67
|
64
|
65
|
75
|
82
|
96
|
112
|
93
|
104
|
132
|
136
|
143
|
|
| Other Current Assets |
0
|
0
|
2
|
3
|
4
|
6
|
9
|
9
|
11
|
10
|
15
|
9
|
10
|
12
|
9
|
15
|
17
|
15
|
20
|
19
|
22
|
23
|
34
|
37
|
|
| Total Current Assets |
22
|
39
|
37
|
41
|
82
|
123
|
132
|
141
|
180
|
166
|
142
|
140
|
194
|
178
|
177
|
211
|
232
|
274
|
307
|
326
|
318
|
349
|
376
|
397
|
|
| PP&E Net |
7
|
10
|
15
|
16
|
22
|
37
|
36
|
33
|
32
|
32
|
36
|
35
|
40
|
40
|
45
|
53
|
56
|
63
|
163
|
171
|
182
|
179
|
186
|
200
|
|
| PP&E Gross |
7
|
10
|
15
|
16
|
22
|
37
|
36
|
33
|
32
|
32
|
36
|
35
|
40
|
40
|
45
|
53
|
56
|
63
|
163
|
171
|
182
|
179
|
186
|
200
|
|
| Accumulated Depreciation |
5
|
7
|
15
|
13
|
17
|
33
|
44
|
48
|
57
|
37
|
42
|
48
|
66
|
66
|
69
|
80
|
90
|
105
|
119
|
109
|
82
|
78
|
80
|
88
|
|
| Intangible Assets |
0
|
1
|
6
|
5
|
47
|
70
|
62
|
45
|
35
|
30
|
30
|
33
|
48
|
41
|
35
|
46
|
45
|
49
|
63
|
60
|
59
|
62
|
66
|
97
|
|
| Goodwill |
0
|
0
|
24
|
25
|
232
|
317
|
342
|
322
|
335
|
339
|
333
|
349
|
397
|
388
|
369
|
394
|
415
|
501
|
521
|
612
|
644
|
680
|
691
|
776
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
1
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
4
|
4
|
7
|
4
|
2
|
7
|
8
|
13
|
15
|
8
|
8
|
17
|
16
|
17
|
25
|
23
|
|
| Other Long-Term Assets |
16
|
21
|
21
|
20
|
24
|
63
|
62
|
62
|
42
|
36
|
32
|
28
|
24
|
22
|
18
|
25
|
24
|
19
|
28
|
28
|
28
|
38
|
42
|
47
|
|
| Other Assets |
0
|
0
|
24
|
25
|
232
|
317
|
342
|
322
|
335
|
339
|
333
|
349
|
397
|
388
|
369
|
394
|
415
|
501
|
521
|
612
|
644
|
680
|
691
|
776
|
|
| Total Assets |
46
N/A
|
71
+55%
|
102
+43%
|
109
+7%
|
408
+275%
|
613
+50%
|
636
+4%
|
604
-5%
|
628
+4%
|
607
-3%
|
580
-4%
|
591
+2%
|
706
+19%
|
678
-4%
|
653
-4%
|
746
+14%
|
793
+6%
|
914
+15%
|
1 091
+19%
|
1 214
+11%
|
1 247
+3%
|
1 325
+6%
|
1 386
+5%
|
1 539
+11%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
3
|
3
|
4
|
3
|
9
|
22
|
15
|
14
|
13
|
15
|
20
|
17
|
21
|
18
|
16
|
18
|
23
|
28
|
27
|
20
|
27
|
29
|
31
|
27
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
22
|
28
|
25
|
18
|
17
|
38
|
40
|
42
|
49
|
56
|
55
|
55
|
56
|
57
|
59
|
74
|
72
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
148
|
76
|
61
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
4
|
5
|
3
|
3
|
11
|
15
|
16
|
21
|
27
|
29
|
21
|
20
|
20
|
0
|
0
|
24
|
25
|
13
|
23
|
35
|
67
|
87
|
43
|
53
|
|
| Other Current Liabilities |
5
|
9
|
12
|
13
|
20
|
31
|
39
|
14
|
10
|
16
|
23
|
21
|
22
|
28
|
23
|
23
|
22
|
21
|
36
|
36
|
35
|
62
|
48
|
58
|
|
| Total Current Liabilities |
12
|
17
|
20
|
19
|
40
|
217
|
146
|
131
|
79
|
85
|
82
|
75
|
102
|
85
|
80
|
114
|
127
|
118
|
141
|
147
|
186
|
237
|
196
|
209
|
|
| Long-Term Debt |
10
|
14
|
36
|
33
|
188
|
201
|
207
|
183
|
210
|
158
|
110
|
84
|
130
|
122
|
84
|
130
|
137
|
222
|
337
|
448
|
381
|
394
|
424
|
447
|
|
| Deferred Income Tax |
0
|
1
|
2
|
3
|
28
|
33
|
29
|
27
|
11
|
14
|
16
|
18
|
21
|
21
|
21
|
29
|
22
|
23
|
30
|
26
|
29
|
30
|
29
|
37
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
5
|
5
|
5
|
0
|
3
|
4
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
3
|
13
|
16
|
6
|
7
|
7
|
6
|
7
|
5
|
7
|
7
|
13
|
14
|
16
|
24
|
29
|
31
|
64
|
|
| Total Liabilities |
22
N/A
|
32
+44%
|
58
+84%
|
54
-7%
|
255
+371%
|
451
+77%
|
386
-15%
|
354
-8%
|
317
-10%
|
265
-16%
|
217
-18%
|
184
-15%
|
260
+41%
|
237
-9%
|
191
-19%
|
280
+46%
|
293
+5%
|
379
+29%
|
526
+39%
|
642
+22%
|
625
-3%
|
690
+10%
|
684
-1%
|
762
+11%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
2
|
3
|
3
|
3
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Retained Earnings |
0
|
9
|
14
|
29
|
41
|
45
|
53
|
81
|
104
|
139
|
173
|
214
|
247
|
296
|
332
|
373
|
424
|
492
|
537
|
533
|
597
|
646
|
707
|
765
|
|
| Additional Paid In Capital |
22
|
27
|
24
|
18
|
104
|
103
|
168
|
168
|
197
|
197
|
189
|
189
|
193
|
164
|
170
|
145
|
109
|
89
|
73
|
70
|
71
|
61
|
61
|
89
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
2
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
1
|
1
|
1
|
|
| Other Equity |
0
|
0
|
2
|
5
|
4
|
9
|
24
|
4
|
6
|
5
|
1
|
0
|
2
|
23
|
44
|
56
|
36
|
50
|
51
|
35
|
51
|
76
|
70
|
83
|
|
| Total Equity |
24
N/A
|
40
+65%
|
44
+10%
|
55
+24%
|
153
+179%
|
162
+6%
|
250
+55%
|
250
0%
|
311
+25%
|
342
+10%
|
363
+6%
|
407
+12%
|
447
+10%
|
441
-1%
|
462
+5%
|
466
+1%
|
500
+7%
|
534
+7%
|
564
+6%
|
573
+1%
|
622
+9%
|
636
+2%
|
702
+10%
|
777
+11%
|
|
| Total Liabilities & Equity |
46
N/A
|
71
+55%
|
102
+43%
|
109
+7%
|
408
+275%
|
613
+50%
|
636
+4%
|
604
-5%
|
628
+4%
|
607
-3%
|
580
-4%
|
591
+2%
|
706
+19%
|
678
-4%
|
653
-4%
|
746
+14%
|
793
+6%
|
914
+15%
|
1 091
+19%
|
1 214
+11%
|
1 247
+3%
|
1 325
+6%
|
1 386
+5%
|
1 539
+11%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
324
|
322
|
318
|
314
|
383
|
385
|
423
|
423
|
454
|
454
|
449
|
449
|
452
|
442
|
444
|
437
|
428
|
424
|
421
|
422
|
422
|
420
|
420
|
427
|
|